Clinipace, Novasep, Lonza and CRF Health are the contract organisations shaking up their senior management in this week's column.
Digital contract research organisation Clinipace has appointed oncology veteran Lee Schacter as Executive Medical Director. He will advise clients on their cancer therapy pipelines.
Before Clinipace, Schacter worked as Senior Director of Global Medical Affairs for Pfizer, Executive Medical Director of Global Head Oncology for MDS Pharma Services, and other roles at Yale School of Medicine, Bristol Myers, Multiple Myeloma Research Foundation, and AstraZeneca.
Clinipace announced this week a move into Asia following the acquisition of pan-Asian firm Choice Pharma.
Copyright - Unless otherwise stated all contents of this web site are © 2015 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Plus promotions and hires in outsourced pharma.